- Home
- STIM vs TETE Comparison
STIM vs TETE Comparison
Compare STIM & TETE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- TETE
- Stock Information
- Founded
- STIM 2003
- TETE 2021
- Country
- STIM United States
- TETE Malaysia
- Employees
- STIM N/A
- TETE N/A
- Industry
- STIM Medical/Dental Instruments
- TETE Blank Checks
- Sector
- STIM Health Care
- TETE Finance
- Exchange
- STIM Nasdaq
- TETE Nasdaq
- Market Cap
- STIM 83.5M
- TETE 73.0M
- IPO Year
- STIM 2018
- TETE 2022
- Fundamental
- Price
- STIM $2.35
- TETE $12.50
- Analyst Decision
- STIM Buy
- TETE
- Analyst Count
- STIM 4
- TETE 0
- Target Price
- STIM $4.67
- TETE N/A
- AVG Volume (30 Days)
- STIM 894.1K
- TETE 6.2K
- Earning Date
- STIM 03-04-2025
- TETE 01-01-0001
- Dividend Yield
- STIM N/A
- TETE N/A
- EPS Growth
- STIM N/A
- TETE N/A
- EPS
- STIM N/A
- TETE 0.02
- Revenue
- STIM $72,711,000.00
- TETE N/A
- Revenue This Year
- STIM $1.97
- TETE N/A
- Revenue Next Year
- STIM $7.96
- TETE N/A
- P/E Ratio
- STIM N/A
- TETE $731.77
- Revenue Growth
- STIM 5.03
- TETE N/A
- 52 Week Low
- STIM $0.52
- TETE $11.45
- 52 Week High
- STIM $5.07
- TETE $13.80
- Technical
- Relative Strength Index (RSI)
- STIM 67.03
- TETE 59.67
- Support Level
- STIM $2.18
- TETE $12.12
- Resistance Level
- STIM $2.65
- TETE $12.28
- Average True Range (ATR)
- STIM 0.29
- TETE 0.02
- MACD
- STIM 0.04
- TETE -0.01
- Stochastic Oscillator
- STIM 65.69
- TETE 100.00
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About TETE Technology & Telecommunication Acquisition Corporation
Technology & Telecommunication Acquisition Corp is a blank check company.